Transcription factor Nrf2 is a master regulator of antioxidant and/or electrophile response elements (AREs/EpREs)-driven genes involved in homeostasis, detoxification and adaptation to various stresses. The cytoprotective activity of Nrf2, though being oppositely involved in both cancer prevention and progression, is critically controlled by Keap1 (Kelch-like ECH-associated protein 1) as an adaptor subunit of Cullin 3-based E3 ubiquitin ligase, that is a key sensor for oxidative and electrophilic stresses. Now, we first report a novel naturally-occurring mutant of Keap1, designated
the ETGE and DLG motifs within the Neh2 domain of Nrf2 [15] , which acts as a degron targeting the CNC-bZIP protein to ubiquitin-mediated proteasomal degradation pathways.
Whilst global knockout of Nrf2 in the mouse does not alter normal physiological development and growth with no spontaneous pathological phenotypes, all Nrf2 -/-animals are more susceptible than wild-type mice to chemical cytotoxicity [16] . By contrast, global knockout of its inhibitor Keap1 causes a constructive enhancement in both protein stability and transactivation activity of Nrf2, but leading to death of all Keap1 -/--deficient mice within three weeks after birth [17, 18] . This lethality is principally attributed to malnutrition caused by severe hyperkeratosis within the upper digestive tract (i.e. esophagus and forestomach). Further analysis of Keap1:Nrf2 double knockout mice has confirmed that the recognizable phenotype of Keap1 -/--deficient mice is attributable to the constitutive activation of Nrf2. To avoid such death of murine pups before weaning, conditional hepatocyte-specific Keap1 -/-mice were generated, as an expected result of viable animals with no apparent abnormalities, but a nuclear moderate accumulation of Nrf2 is elevated in order to activate the CNC-bZIP factor and confer its potent resistance against acute drug toxicity [19] . Despite cytoprotective function of Nrf2 supported by graded expression of Keap1, a marked decrease of its levels to less than 50% results in increased mortality in a study of 2-year-old mice [20] . Overall, these facts demonstrate that the benefits of modest cytoprotective activation of Nrf2 against acute toxicity are hormetic, but its constitutive activation beyond a certain threshold is rather disadvantageous to long-term survival. The notion is supported by permanently hyperactive Nrf2 allowing for its transfiguration to act as an unrecognized mediator of oncogenesis and promote cancer cell survival in tumorigenesis [21, 22] . Hence, such distinct dual roles of Nrf2 (to become a good friend or dangerous foe) in tumor prevention and progression have led us to take careful account of its opposing potentials to implicate in cancer treatment.
Subsequent sequencing of the cDNA products from MHCC97H cells revealed that overlapped double peaks emerged from the 1326th nucleotide of the Keap1-coding region (Fig. 1C) . To clarify the overlapped double peaks of the above-described Keap1 cDNA sequences, they were subcloned into the pcDNA3 expression vector, before 14 clones were randomly selected and identified by PCR with a pair of Keap1 primers. The resulting electrophoresis of PCR products showed two types of bands with distinct sizes, though both were migrated closely to the standard 2000-bp DNA marker, on 1.0% Agarose gels (Fig. 1D) Hacat (skin) and HEK293 (kidney). Overall, expression of Keap1 ΔC mRNA was at relatively higher levels determined primarily in MHCC97H, Huh7 and A2780 cells than other cell lines, but its bona fide abundances were also presented at considerable lower levels than the value of wild-type Keap1 mRNA in all examined cell lines. (Fig. 3A1 ). This result is too coincidental to be just a coincidence, along with almost none of Keap1 detected in MHCC97H cells (Fig. 3A2 ), but as accompanied by relative higher levels of Keap1 ΔC (Fig. 2E ). This finding indicates that the increase of Nrf2 should be attributable to remarked expression of Keap1 ΔC . This notion is also supported by additional opposing fact that no increased, but considerable lower, levels of Nrf2 (Fig. 3A1) (Fig. 3A2) , along with very lower expression levels of Keap1 ΔC (Fig. 2E) , led to marked decreases of Nrf2 to similar lower levels that measured from HL7702 cells (Fig. 3A1) . Together, the non-cancerous HL7702 cells are allowed for maintaining proper constructive thresholds of Keap1 and Nrf2 to be expressed at controllable lower levels. In turn, it is inferable to exist a potential relevance of malignant hepatoma development to the constructive increases in basal Nrf2 or Keap1 proteins, which should also be affected by differential expression of Keap1 ΔC . Further examinations of these cancerous and non-cancerous cells revealed a coupled positive and negative correlation of Nrf2 and Keap1, respectively, with basal protein expression levels of Nrf2-target genes HO-1 and GLCM, but not NQO1 (Fig. 3A3 to A5 ). Such an exception of NQO1 that was highly expressed in HL7702 and HepG2 cell lines (Fig. 3A5) , though accompanied by lower levels of Nrf2, indicates that it may also be regulated by other CNC-bZIP family members (e.g. Nrf1) and other transcription factors (e.g. AP-1) [27, 28] .
To determine whether inhibition of Nrf2-mediated gene transcription by Keap1 is interfered by Keap1 ΔC , both MHCC97H and HepG2 cell lines were co-transfected with a Keap1 or Keap1 ΔC expression construct together with an ARE-driven luciferase reporter. The results showed that over-expression of Keap1 caused a significant decrease in ARE-Luc reporter activity to ~30% of control levels (Fig. 3B , that were measured from transfection of MHCC97H cells with an empty pcDNA3 vector and the reporter). However, such a decreased transactivation activity of ARE-Luc reporter gene mediated by endogenous Nrf2 appeared to be, at least in part, disinhibited by endogenous Keap1 ΔC to a certain extent, albeit over-expression of Keap1 ΔC only resulted in slight repression of the reporter gene activity in the same MHCC97H cells (Fig. 3B) . By contrast, Nrf2-transacting ARE-Luc reporter activity was almost unaffected by ectopic Keap1 or Keap1 ΔC in HepG2 cells (Fig. 3C ). This is postulated to be owing to a considerable higher background of endogenous Keap1, so that Nrf2-targeted gene reporter may be not over-regulated by further over-expression of (Fig. 3G) . This implies that transcription of HO-1 is regulated by Nrf2 in a steady-state system. In addition, basal GCLM and NQO1 l mRNAs appeared to be unaffected by either Keap1 or Keap1 ΔC (Fig. 3H & I), but a marginal increase in Nrf2-induced GCLM rather than NQO1 expression was diminished by Keap1. This was roughly not or less decreased by Keap1 ΔC in MHCC97H and HepG2 cells. 
Keap1 ΔC acts as a dominant-negative competitor against intact Keap1
To provide a better understanding of the axiomatic reason why Keap1 ΔC is enabled for its interference with Keap1, we conducted molecular modeling of two possible dimeric complexes of Keap1 ΔC (only retaining two Ketch motifs)
with intact Keap1 (with all six Ketch motifs and adjacent C-terminal region, which are essential for direct association with Nrf2) (Fig. 4A ). These models were based on a known crystal structure of Keap1 in complex with the N-terminal Neh2 region of Nrf2 (i.e. 3WN7 deposited in PDB) [15, 29, 30] . From formation of an invalid dimer of Keap1 ΔC :Keap1 and Keap1 ΔC :Keap1 ΔC (Fig. 4A, right panels) , it is therefore deduced that they do not only enable intact Keap1 to be simply consumed, but act as a potential dominant-negative competitor of Keap1 against its functional interaction with Nrf2.
To verify whether Keap1 ΔC has a marginal negativity to regulate Nrf2 through its residual DGR region, we created a series of expression constructs. Of note, the Keap1 N321 mutant lacks the entire DGR domain, but retains its N-terminal 321-aa region, while Keap1 ΔN is an N-terminal deletion mutant, which comprises only 303 aa covering the entire DGR domain of Keap1 to its C-terminal end (Fig. 4B) . Subsequently, ARE-driven luciferase reporter assays of HepG2 (Fig. 4C ) and MHCC97H (Fig. 4D ) cell lines demonstrated that Nrf2-mediated transactivation activity was significantly suppressed by Keap1, but was only marginally or not diminished by Keap1 ΔC . The low-efficient effect of 9 N-terminally V5-tagged polypeptide of ~8-kDa was, by coincidence, yielded from the putative N-terminal proteolytic processing of Keap1 or Keap1 ΔC (Fig. 4I, lanes 14 & 15 in upper two panels) . Moreover, immunoblotting of Keap1 ΔN unraveled that additional post-synthetic processing of Keap1 might also occur within a region closer to its C-terminal end, such that the majority of the C-terminally-tagged V5 ectope of this mutant was truncated off the protein, albeit the remaining portion of Keap1 ΔN was still recognized by Keap1-specific antibody (Fig. 4G, lane 6 vs Fig. 4H, lane 12) .
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Further time-course analysis of CHX-treated MHCC97H cells revealed that endogenous Nrf2 protein levels were modestly reduced by over-expression of Keap1, rather than Keap1 ΔC (Fig. 5E ), but its half-life was obviously extended by Keap1 ΔC from 0.39 h (=23.4 min) to 0.62 h (=37.2 min) following CHX treatment (Fig. 5F ). Taken together with the data shown in Fig. 2E , these suggest that endogenous Keap1 ΔC may compete Keap1, leading to de-repression of Keap1-mediated turnover of Nrf2 protein in MHCC97H cells. However, a marked increase in the endogenous CNC-bZIP protein was observed following treatment of HepG2 cells with proteasomal inhibitor MG132 (at 10 mol/L) (Fig. 5G) . Notably, over-expression of Keap1 rather than Keap1 ΔC caused significant decreases in baseline abundance and MG132-stimulated accumulation of endogenous Nrf2 protein in HepG2 cells. Taken together, these results demonstrate that Keap1, but not Keap1 ΔC , is required for targeting Nrf2 to the proteasomal-mediated degradation pathway (Fig. 5H) . upon dissociation of Nrf2 from Keap1, the CNC-bZIP factor will be allowed for spatio-temporal translocation into the nucleus before transactivating ARE-driven cytoprotective genes against oxidative stress or other biological stimuli.
CONCLUSION
As the most important inhibitory regulator of Nrf2, Keap1 plays a key role in monitoring the protein degradation of this CNC-bZIP factor and its subcellular locations, before regulating ARE-driven target genes [32, 33] . Here, we report a novel discovery of Keap1 ΔC , as a naturally-occurring mutant of Keap1 with a constructive deletion of its C-terminal
Expression constructs and transfection
The human full-length Nrf2, Keap1 and Keap1 ΔC cDNA sequences were subcloned into a pcDNA3 vector, respectively.
Deletion mutants of Keap1 were created by inserting appropriate PCR-amplified cDNA fragments into the above-described vector. Related primers were listed in Table 1 . These mutants included Keap1 ΔN (with a deletion of the N-terminal 321-aa from Keap1), Keap1 N321 (only retaining the N-terminal 321-aa region). In addition, they were N-terminally or C-terminally tagged by the V5 ectope to yield distinct strategic expression constructs. Following all these constructs were verified by DNA sequencing, they were transfected into experimental cells (2.5×10 5 ), which had been allowed for growth to a confluence of 80% in 35-mm culture dishes. The transfection was carried out for 15-min in a mixture of indicated constructs (2 g/ml) with Lipofectamine 3000 (Invitrogen, USA), and then allowed for a recovery from transfection before being experimented. Table 1 . Distinct pairs of primers used for expression constructs and PT-qPCR analysis
Luciferase reporter assay
A pARE-Luc reporter plasmid [34] , which was used for a measure of the transactivation activity of ARE-driven gene mediated by Nrf2, and pRL-TK, which is an internal control of Renilla luciferase reporter, together with indicated expression constructs were co-transfected into HepG2 or MHCC97H cells. At about 24 h after transfection, the luciferase reporter activity was measured by using dual luciferase reporter assay (Promega, USA).
Real-time quantitative PCR
Experimental cells that had been transfected or not been transfected with the indicated plasmids were subjected to isolation of total RNAs by using the RNAsimple Kit (Tiangen Biotech CO., Beijing). Subsequently, 500 ng of total RNAs was added in a reverse-transcriptase reaction to generate the first strand of cDNA (with Revert Aid First Strand Synthesis Kit from Thermo). The synthesized cDNA was served as the template for qPCR, in the GoTaq® qPCR Master Mix (from Promega), before being deactivated at 95℃ for 10 min, and amplified by 40 reaction cycles of 15 s at 95℃
and 30 s at 60℃. The final melting curve was validated to examine the amplification quality, whereas expression of mRNA for β-actin was viewed as an internal standard control.
